Mechanisms involved in the enhancement of mammalian target of rapamycin signalling and hypertrophy in skeletal muscle of myostatin-deficient mice

FEBS Lett. 2010 Jun 3;584(11):2403-8. doi: 10.1016/j.febslet.2010.04.039. Epub 2010 Apr 20.

Abstract

Myostatin deficiency leads to both an increased rate of protein synthesis and skeletal muscle hypertrophy. However, the mechanisms involved in mediating these effects are not yet fully understood. Here, we demonstrate that genetic loss of myostatin leads to enhanced muscle expression of both protein kinase B and mammalian target of rapamycin/S6K signalling components, consistent with their elevated activity. This is associated with a reduction in the expression of PGC1alpha and COX IV, proteins which play important roles in maintaining mitochondrial function. Furthermore, we show that these changes in signalling and protein expression are largely independent of alterations in intramuscular amino acid content. Our findings, therefore, reveal potential new mechanisms and further contribute to our understanding of myostatin-regulated skeletal muscle growth and function.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Hypertrophy / metabolism
  • Mammals / genetics
  • Mammals / metabolism
  • Mice
  • Muscle Development / genetics*
  • Muscle, Skeletal / metabolism*
  • Myostatin
  • Protein Biosynthesis
  • Proteins / genetics
  • Proteins / metabolism
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction / genetics*
  • Sirolimus / metabolism*

Substances

  • Myostatin
  • Proteins
  • Proto-Oncogene Proteins c-akt
  • Sirolimus